{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:48:06Z","timestamp":1793933286864,"version":"4.8.0"},"reference-count":121,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Group A<jats:italic>Streptococcus<\/jats:italic>(GAS;<jats:italic>Streptococcus pyogenes<\/jats:italic>) is a nearly ubiquitous human pathogen responsible for a significant global disease burden. No vaccine exists, so antibiotics are essential for effective treatment. Despite a lower incidence of antimicrobial resistance than many pathogens, GAS is still a top 10 cause of death due to infections worldwide. The morbidity and mortality are primarily a consequence of the immune sequelae and invasive infections that are difficult to treat with antibiotics. GAS has remained susceptible to penicillin and other \u03b2-lactams, despite their widespread use for 80 years. However, the failure of treatment for invasive infections with penicillin has been consistently reported since the introduction of antibiotics, and strains with reduced susceptibility to \u03b2-lactams have emerged. Furthermore, isolates responsible for outbreaks of severe infections are increasingly resistant to other antibiotics of choice, such as clindamycin and macrolides. This review focuses on the challenges in the treatment of GAS infection, the mechanisms that contribute to antibiotic failure, and adjunctive therapeutics. Further understanding of these processes will be necessary for improving the treatment of high-risk GAS infections and surveillance for non-susceptible or resistant isolates. These insights will also help guide treatments against other leading pathogens for which conventional antibiotic strategies are increasingly failing.<\/jats:p>","DOI":"10.3389\/fmicb.2021.760255","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T06:52:40Z","timestamp":1636008760000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":65,"title":["Antibiotic Treatment, Mechanisms for Failure, and Adjunctive Therapies for Infections by Group A Streptococcus"],"prefix":"10.3389","volume":"12","author":[{"given":"Anders F.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher N.","family":"LaRock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0923-1811(03)00096-3","article-title":"Assessment of Streptococcus pyogenes microcolony formation in infected skin by confocal laser scanning microscopy.","volume":"32","author":"Akiyama","year":"2003","journal-title":"J. Dermatol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e00133","DOI":"10.1128\/IAI.00133-20","article-title":"A role of epithelial cells and virulence factors in biofilm formation by streptococcus pyogenes in vitro.","volume":"88","author":"Alamiri","year":"2020","journal-title":"Infect. Immun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1086\/319373","article-title":"Comparative in vitro activity of moxifloxacin by E-test against Streptococcus pyogenes.","volume":"32","author":"Am\u00e1bile-Cuevas","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/infdis\/jiw229","article-title":"Clindamycin affects group a Streptococcus virulence factors and improves clinical outcome.","volume":"215","author":"Andreoni","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1128\/JCM.00512-06","article-title":"Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation.","volume":"44","author":"Baldassarri","year":"2006","journal-title":"J. Clin. Microbiol. Am. Soc. Microbiol. J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.chom.2013.11.003","article-title":"The globally disseminated M1T1 clone of group a Streptococcus evades autophagy for intracellular replication.","volume":"14","author":"Barnett","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B7","doi-asserted-by":"publisher","first-page":"15877","DOI":"10.1038\/srep15877","article-title":"Transfer of scarlet fever-associated elements into the group a Streptococcus M1T1 clone.","volume":"5","author":"Ben Zakour","year":"2015","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.18502\/ijm.v11i1.698","article-title":"Trend of antibiotic susceptibility of Streptococcus pyogenes isolated from respiratory tract infections in tertiary care hospital in south Karnataka.","volume":"11","author":"Berwal","year":"2019","journal-title":"Iran J. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e013260","DOI":"10.1136\/bmjopen-2016-013260","article-title":"Adjunctive clindamycin for cellulitis: a clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis.","volume":"7","author":"Brindle","year":"2017","journal-title":"BMJ Open"},{"key":"B10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1001\/archotol.1984.00800300020004","article-title":"\u03b2-lactamase\u2014producing bacteria recovered after clinical failures with various penicillin therapy.","volume":"110","author":"Brook","year":"1984","journal-title":"Arch. Otolaryngol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/1471-2334-9-202","article-title":"The role of beta-lactamase-producing-bacteria in mixed infections.","volume":"9","author":"Brook","year":"2009","journal-title":"BMC Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/000992288502400606","article-title":"Treatment of patients with a history of recurrent tonsillitis due to group a beta-hemolytic Streptococci: a prospective randomized study comparing penicillin, erythromycin, and clindamycin.","volume":"24","author":"Brook","year":"1985","journal-title":"Clin. Pediatr. (Phila)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/cid\/ciaa027","article-title":"Risk factors and predictors of mortality in Streptococcal necrotizing soft-tissue infections: a multicenter prospective study.","volume":"72","author":"Bruun","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1086\/432729","article-title":"Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: the role of streptolysin O\u2013induced platelet\/neutrophil complexes.","volume":"192","author":"Bryant","year":"2005","journal-title":"J. Infect. Dis."},{"key":"B15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.7883\/yoken.JJID.2006.334","article-title":"Resistance to erythromycin and rising penicillin MIC in Streptococcus pyogenes in India.","volume":"59","author":"Capoor","year":"2006","journal-title":"JPN J. Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/cid\/ciu304","article-title":"Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a Streptococcal infections.","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clin. Infect. Dis. Oxford Acad."},{"key":"B17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group a Streptococcal diseases.","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1046\/j.1365-2958.1996.01521.x","article-title":"Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes.","volume":"22","author":"Clancy","year":"1996","journal-title":"Mol. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e4166","DOI":"10.1371\/journal.pone.0004166","article-title":"Relationship between expression of the family of M Proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes.","volume":"4","author":"Courtney","year":"2009","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1592\/phco.23.5.638.32191","article-title":"Targeting bacterial virulence: the role of protein synthesis inhibitors in severe infections.","volume":"23","author":"Coyle","year":"2003","journal-title":"Pharmacotherapy"},{"key":"B21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/CMR.13.3.470","article-title":"Pathogenesis of group A Streptococcal infections.","volume":"13","author":"Cunningham","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"eaau3776","DOI":"10.1126\/scitranslmed.aau3776","article-title":"Recurrent group A Streptococcus tonsillitis is an immunosusceptibility disease involving antibody deficiency and aberrant TFH cells.","volume":"11","author":"Dan","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/376630","article-title":"StreptIg study group. intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial.","volume":"37","author":"Darenberg","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/ng.3147","article-title":"Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance.","volume":"47","author":"Davies","year":"2015","journal-title":"Nat. Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1007\/s00134-015-3916-9","article-title":"Henri mondor hospital necrotizing fasciitis group. Management of necrotizing soft tissue infections in the intensive care unit: results of an international survey.","volume":"41","author":"de Prost","year":"2015","journal-title":"Intensive Care Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/INF.0000000000001442","article-title":"Macrolide and clindamycin resistance in group a Streptococci isolated from children with pharyngitis.","volume":"36","author":"DeMuri","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1423-0410.2012.01648.x","article-title":"In vitro and in vivo properties differ among liquid intravenous immunoglobulin preparations.","volume":"104","author":"Dhainaut","year":"2013","journal-title":"Vox Sang."},{"key":"B28","doi-asserted-by":"publisher","first-page":"43039","DOI":"10.1038\/srep43039","article-title":"Group a Streptococcal M1 protein provides resistance against the antimicrobial activity of histones.","volume":"7","author":"D\u00f6hrmann","year":"2017","journal-title":"Sci. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"8842","DOI":"10.1073\/pnas.86.22.8842","article-title":"Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae.","volume":"86","author":"Dowson","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0002-9343(52)90293-3","article-title":"Experimental approach to the problem of treatment failure with penicillin: I. Group a streptococcal infection in mice.","volume":"13","author":"Eagle","year":"1952","journal-title":"Am. J. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.88.1.99","article-title":"The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms.","volume":"88","author":"Eagle","year":"1948","journal-title":"J. Exp. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"ciab575","DOI":"10.1093\/cid\/ciab575","article-title":"Patterns of antibiotic nonsusceptibility among invasive group a Streptococcus infections\u2014United States, 2006\u20132017.","volume":"2021","author":"Fay","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1046\/j.1365-2958.2000.02084.x","article-title":"Virulent aggregates of Streptococcus pyogenes are generated by homophilic protein\u2013protein interactions.","volume":"37","author":"Frick","year":"2000","journal-title":"Mol. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1172\/JCI110152","article-title":"Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of Clindamycin.","volume":"67","author":"Gemmell","year":"1981","journal-title":"J. Clin. Invest."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/S0140-6736(05)61327-X","article-title":"Failure of penicillin in Streptococcus pyogenes pharyngeal infection.","volume":"352","author":"Gillespie","year":"1998","journal-title":"Lancet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e00012","DOI":"10.1128\/IAI.00012-20","article-title":"Antibiotic degradation by commensal microbes shields pathogens.","volume":"88","author":"Gjonbalaj","year":"2020","journal-title":"Infect. Immun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1128\/AAC.40.4.829","article-title":"Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics.","volume":"40","author":"Grebe","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1128\/AAC.22.1.128","article-title":"Penicillin-resistant and penicillin-tolerant mutants of group a Streptococci.","volume":"22","author":"Gutmann","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1128\/AAC.19.5.872","article-title":"Physiological properties of penicillin-binding proteins in group a Streptococci.","volume":"19","author":"Gutmann","year":"1981","journal-title":"Antimicrob. Agents Chemother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/cid\/ciz1006","article-title":"Streptococcus pyogenes With reduced susceptibility to \u03b2-lactams: how big an alarm bell?","volume":"71","author":"Hanage","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e00090","DOI":"10.1128\/mSphere.00090-20","article-title":"Restricted sequence variation in Streptococcus pyogenes penicillin binding proteins.","volume":"5","author":"Hayes","year":"2020","journal-title":"mSphere"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e35218","DOI":"10.1371\/journal.pone.0035218","article-title":"Intracellular Streptococcus pyogenes in human macrophages display an altered gene expression profile.","volume":"7","author":"Hertz\u00e9n","year":"2012","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1086\/516375","article-title":"Why have group a Streptococci remained susceptible to penicillin? Report on a symposium.","volume":"26","author":"Horn","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.meegid.2018.03.006","article-title":"Streptococcal pharyngitis and rheumatic heart disease: the superantigen hypothesis revisited.","volume":"61","author":"Hurst","year":"2018","journal-title":"Infec. Genet. Evol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/NEJM199911253412203","article-title":"Epidemics of diarrhea caused by a clindamycin-resistant strain of clostridium difficile in four hospitals.","volume":"341","author":"Johnson","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1086\/508773","article-title":"Reduced ability of penicillin to eradicate ingested group a Streptococci from epithelial cells: clinical and pathogenetic implications.","volume":"43","author":"Kaplan","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.autrev.2006.08.011","article-title":"Safety of intravenous immunoglobulin (IVIG) therapy.","volume":"6","author":"Katz","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome\u2013a comparative observational study. The Canadian Streptococcal Study Group.","volume":"28","author":"Kaul","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s40262-014-0152-3","article-title":"Comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring.","volume":"53","author":"Kiang","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1128\/AAC.43.3.616","article-title":"Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1\u03b2.","volume":"43","author":"Kishi","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1128\/JCM.00422-08","article-title":"Epidemiology of severe Streptococcus pyogenes disease in Europe.","volume":"46","author":"Lamagni","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1365-2133.2002.04665.x","article-title":"Cutaneous adverse reactions to clindamycin: results of skin tests and oral exposure.","volume":"146","author":"Lammintausta","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.chom.2015.09.004","article-title":"Group a streptococcal M1 protein sequesters cathelicidin to evade innate immune killing.","volume":"18","author":"LaRock","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e00356","DOI":"10.1128\/IAI.00356-20","article-title":"Group A Streptococcus infection of the nasopharynx requires proinflammatory signaling through the interleukin-1 receptor.","volume":"88","author":"LaRock","year":"2020","journal-title":"Infect. Immun."},{"key":"B55","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1086\/426894","article-title":"Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned?","volume":"40","author":"Lewis","year":"2005","journal-title":"Clinical Infectious Diseases."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1128\/AAC.01877-13","article-title":"Failure of clindamycin to eradicate infection with beta-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections.","volume":"58","author":"Lewis","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/cid\/ciu449","article-title":"Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.","volume":"59","author":"Linn\u00e9r","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B58","first-page":"135","article-title":"Penicillin\u2019s discovery and antibiotic resistance: lessons for the future?","volume":"90","author":"Lobanovska","year":"2017","journal-title":"Yale J. Biol. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ccc.2013.03.012","article-title":"Toxic shock syndrome: major advances in pathogenesis, but not treatment.","volume":"29","author":"Low","year":"2013","journal-title":"Crit. Care Clin."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S1473-3099(19)30446-3","article-title":"Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study.","volume":"19","author":"Lynskey","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00006454-199805000-00006","article-title":"Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades.","volume":"17","author":"Macris","year":"1998","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B62","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11882-014-0476-y","article-title":"Penicillin and beta-lactam allergy: epidemiology and diagnosis.","volume":"14","author":"Macy","year":"2014","journal-title":"Curr. Allergy Asthma Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jaip.2013.02.002","article-title":"Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin.","volume":"1","author":"Macy","year":"2013","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00134-017-4786-0","article-title":"Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial.","volume":"43","author":"Madsen","year":"2017","journal-title":"Intensive Care Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1365-2958.2007.05704.x","article-title":"Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation.","volume":"64","author":"Manetti","year":"2007","journal-title":"Mol. Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0022-3476(05)80840-6","article-title":"Treatment of streptococcal pharyngotonsillitis: Reports of penicillin\u2019s demise are premature.","volume":"123","author":"Markowitz","year":"1993","journal-title":"J. Pediatr."},{"key":"B67","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/infdis\/jiu058","article-title":"Streptococcus pyogenes biofilm growth in vitro and in vivo and its role in colonization, virulence, and genetic exchange.","volume":"210","author":"Marks","year":"2014","journal-title":"J. Infect. Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0924-8579(01)00413-7","article-title":"Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci.","volume":"18","author":"Mascini","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B69","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1248\/yakushi1947.120.4_374","article-title":"Study of macrolide, lincosamide, and streptogramin B antibiotics resistance in Staphylococcus aureus.","volume":"120","author":"Matsuoka","year":"2000","journal-title":"Yakugaku Zasshi"},{"key":"B70","doi-asserted-by":"publisher","first-page":"100013","DOI":"10.1016\/j.bioflm.2019.100013","article-title":"Cellular chaining influences biofilm formation and structure in group A Streptococcus.","volume":"2","author":"Matysik","year":"2020","journal-title":"Biofilm"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e01993","DOI":"10.1128\/JCM.01993-19","article-title":"Reduced in vitro susceptibility of Streptococcus pyogenes to \u03b2-lactam antibiotics associated with mutations in the pbp2x gene is geographically widespread.","volume":"58","author":"Musser","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1086\/514588","article-title":"Varying titers of neutralizing antibodies to Streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy.","volume":"26","author":"Norrby-Teglund","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1574-6968.2011.02252.x","article-title":"Epidemiological characterization of Streptococcus pyogenes isolated from patients with multiple onsets of pharyngitis.","volume":"318","author":"Ogawa","year":"2011","journal-title":"FEMS Microbiol. Lett."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-pathol-121808-102135","article-title":"Molecular pathogenesis of necrotizing fasciitis.","volume":"5","author":"Olsen","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.ajpath.2020.04.014","article-title":"Single amino acid replacement in penicillin-binding protein 2X in Streptococcus pyogenes significantly increases fitness on subtherapeutic benzylpenicillin treatment in a mouse model of necrotizing myositis.","volume":"190","author":"Olsen","year":"2020","journal-title":"Am. J. Pathol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-3-030-57616-5_7","article-title":"Treatment of necrotizing soft tissue infections: antibiotics","author":"Oppegaard","year":"2020","journal-title":"Necrotizing Soft Tissue Infections: Clinical and Pathogenic Aspects"},{"key":"B77","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/000348940111000716","article-title":"Penicillin treatment failure in group A streptococcal tonsillopharyngitis: no genetic difference found between strains isolated from failures and nonfailures.","volume":"110","author":"Orrling","year":"2001","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3109\/00365549409011811","article-title":"Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment.","volume":"26","author":"Orrling","year":"1994","journal-title":"Scand. J. Infect. Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3201\/eid2304.160773","article-title":"Incidence and characteristics of Scarlet Fever, South Korea, 2008-2015.","volume":"23","author":"Park","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/cid\/ciy401","article-title":"Polyspecific intravenous immunoglobulin in clindamycin-treated patients with streptococcal toxic shock syndrome: a systematic review and meta-analysis.","volume":"67","author":"Parks","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0887-7963(03)00038-5","article-title":"Risks associated with the use of intravenous immunoglobulin.","volume":"17","author":"Pierce","year":"2003","journal-title":"Transfu. Med. Rev."},{"key":"B82","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.tim.2018.10.007","article-title":"The eagle effect and antibiotic-induced persistence: two sides of the same coin?","volume":"27","author":"Prasetyoputri","year":"2019","journal-title":"Trends Microbiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/clinids\/11.6.928","article-title":"Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever.","volume":"11","author":"Quinn","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1086\/432473","article-title":"Macrolide-resistant Streptococcus pyogenes in the United States, 2002\u20132003.","volume":"41","author":"Richter","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B85","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2431-12-3","article-title":"Detection of group A streptococcus in tonsils from pediatric patients reveals high rate of asymptomatic streptococcal carriage.","volume":"12","author":"Roberts","year":"2012","journal-title":"BMC Pediatr."},{"key":"B86","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1699-0463.1958.tb03183.x","article-title":"Investigations of penicillin-resistant streptococci belonging to group A.","volume":"42","author":"Rosendal","year":"1958","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"B87","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13017-018-0219-9","article-title":"2018 WSES\/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections.","volume":"13","author":"Sartelli","year":"2018","journal-title":"World J. Emerg. Surg."},{"key":"B88","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/infdis\/149.3.471","article-title":"Clindamycin-induced suppression of toxic-shock syndrome-associated exotoxin production.","volume":"149","author":"Schlievert","year":"1984","journal-title":"J. Infect. Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1086\/507037","article-title":"Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome.","volume":"43","author":"Schrage","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1099\/0022-1317-49-6-499","article-title":"Relationship between asymptomatic carriage of Streptococcus pyogenes and the ability of the strains to adhere to and be internalised by cultured epithelial cells.","volume":"49","author":"Sela","year":"2000","journal-title":"J. Med. Microbiol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1128\/AAC.42.2.257","article-title":"Novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes.","volume":"42","author":"Sepp\u00e4l\u00e4","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e557","DOI":"10.1542\/peds.2009-2648","article-title":"Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis.","volume":"126","author":"Shaikh","year":"2010","journal-title":"Pediatrics"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/9781683670131.ch5","article-title":"Toxins and superantigens of group A streptococci.","volume":"7","author":"Shannon","year":"2019","journal-title":"Microbiol. Spectrum"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e87882","DOI":"10.1172\/jci.insight.87882","article-title":"Biofilm in group A streptococcal necrotizing soft tissue infections.","volume":"1","author":"Siemens","year":"2016","journal-title":"JCI Insight"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e2000631","DOI":"10.1371\/journal.pbio.2000631","article-title":"Collective resistance in microbial communities by intracellular antibiotic deactivation.","volume":"14","author":"Sorg","year":"2016","journal-title":"PLoS Biol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.anai.2017.07.009","article-title":"Frequency of self-reported drug allergy: a systematic review and meta-analysis with meta-regression.","volume":"119","author":"Sousa-Pinto","year":"2017","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00253-003-1545-7","article-title":"Lincomycin, clindamycin and their applications.","volume":"64","author":"Sp\u00edzek","year":"2004","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/jac\/dkl173","article-title":"Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.","volume":"58","author":"Sriskandan","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"B100","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/jac\/40.2.275","article-title":"Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes.","volume":"40","author":"Sriskandan","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice Guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1056\/NEJMra1600673","article-title":"Necrotizing soft-tissue infections.","volume":"377","author":"Stevens","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1093\/clinids\/20.Supplement_2.S154","article-title":"Antibiotic effects on bacterial viability, toxin production, and host response.","volume":"20","author":"Stevens","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/infdis\/158.1.23","article-title":"The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.","volume":"158","author":"Stevens","year":"1988","journal-title":"J. Infect. Dis."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1128\/AAC.42.5.1266","article-title":"In vitro antimicrobial effects of various combinations of penicillin and clindamycin against four strains of Streptococcus pyogenes.","volume":"42","author":"Stevens","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B106","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/infdis\/155.2.220","article-title":"Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens.","volume":"155","author":"Stevens","year":"1987","journal-title":"J. Infect. Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM198907063210101","article-title":"Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.","volume":"321","author":"Stevens","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/ddg.13790","article-title":"S2k guidelines for skin and soft tissue infections Excerpts from the S2k guidelines for \u201ccalculated initial parenteral treatment of bacterial infections in adults \u2013 update 2018\u201d.","volume":"17","author":"Sunderk\u00f6tter","year":"2019","journal-title":"J. Dtch Dermatol. Ges."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1128\/AAC.40.8.1817","article-title":"Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.","volume":"40","author":"Sutcliffe","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"B110","doi-asserted-by":"publisher","first-page":"512.e7","DOI":"10.1016\/j.cmi.2018.07.007","article-title":"Human polyspecific immunoglobulin attenuates group A streptococcal virulence factor activity and reduces disease severity in a murine necrotizing fasciitis model.","volume":"25","author":"Tarnutzer","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"B111","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","article-title":"Antibiotic penetration into bone and joints: an updated review.","volume":"81","author":"Thabit","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"B112","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/cid\/ciz1000","article-title":"Streptococcus pyogenes pbp2x mutation confers reduced susceptibility to \u03b2-Lactam antibiotics.","volume":"71","author":"Vannice","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B113","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/antibiotics9110775","article-title":"Assessing the role of pharyngeal cell surface glycans in group A streptococcus biofilm formation.","volume":"9","author":"Vyas","year":"2020","journal-title":"Antibiotics"},{"key":"B114","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1128\/CMR.00101-13","article-title":"Disease manifestations and pathogenic mechanisms of group A streptococcus.","volume":"27","author":"Walker","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"B115","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: transmission, colonization and invasion.","volume":"16","author":"Weiser","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"704099","DOI":"10.3389\/fcimb.2021.704099","article-title":"Playing with fire: proinflammatory virulence mechanisms of group A streptococcus.","volume":"11","author":"Wilde","year":"","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/infdis\/jiaa511","article-title":"Opportunistic invasive infection by group A streptococcus during anti-interleukin-6 immunotherapy.","volume":"223","author":"Wilde","year":"","journal-title":"J. Infect. Dis."},{"key":"B118","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.mib.2005.08.016","article-title":"\u03b2-Lactam antibiotic resistance: a current structural perspective.","volume":"8","author":"Wilke","year":"2005","journal-title":"Curr. Opin. Microbiol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1016\/S0163-4453(17)30206-2","article-title":"Toxic shock syndrome\u2013the seven Rs of management and treatment.","volume":"74","author":"Wilkins","year":"2017","journal-title":"J. Infect."},{"key":"B120","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1189\/jlb.4MR0316-153RR","article-title":"Inflammatory properties of antibiotic-treated bacteria.","volume":"101","author":"Wolf","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.micpath.2017.03.002","article-title":"Toxin production of Clostridium difficile in sub-MIC of vancomycin and clindamycin alone and in combination with ceftazidime.","volume":"107","author":"Zarandi","year":"2017","journal-title":"Microb. Pathog."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.760255\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T13:26:08Z","timestamp":1726061168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.760255\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":121,"alternative-id":["10.3389\/fmicb.2021.760255"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.760255","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,4]]},"article-number":"760255"}}